-
This comes on top of less-than-positive results concerning a late-stage study of Erbitux, ImClone's multi-billion colorectal drug, combined with chemotherapy.
FORBES: Market Scan
-
They are also conducting a study comparing their medicine combined with chemotherapy versus a combination of Avastin, panitumumab and chemo.
FORBES
-
Back in 2001, a plan was in the works for a study comparing Erbitux combined with chemotherapy to chemo alone for front-line use.
FORBES: ImClone's Next Hurdles: Cost And Competition
-
Erbitux is only modestly effective--it shrinks tumors in only 23% of patients when combined with chemotherapy, and it hasn't been proven to extend life.
FORBES: Erbitux: Nothing Special
-
The high dose MIBG was combined with more standard chemotherapy treatment.
BBC: Therapy shrinks advanced tumours